blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1758597

EP1758597 - USE OF DRUG COMBINATIONS FOR TREATING INSULIN RESISTANCE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  19.07.2013
Database last updated on 11.09.2024
Most recent event   Tooltip17.07.2015Lapse of the patent in a contracting state
New state(s): HU, LU		published on 19.08.2015  [2015/34]
Applicant(s)For all designated states
Diamedica Inc.
6 - 1200 Waverley Street Winnipeg
Manitoba R3T 0P4 / CA
[2007/10]
Inventor(s)01 / LAUTT, Wayne, W.
2104-1960 St. Mary's Road
Winnipeg, Manitoba R3N 4M7 / CA
 [2007/10]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [2012/37]Vossius & Partner
Siebertstrasse 4
81675 München / DE
Former [2008/35]Vossius & Partner
Siebertstrasse 3
81675 München / DE
Former [2007/10]Vossius & Partner
Siebertstrasse 4
81675 München / DE
Application number, filing date05748807.420.05.2005
[2007/10]
WO2005CA00775
Priority number, dateUS20040572486P20.05.2004         Original published format: US 572486 P
[2007/10]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005112949
Date:01.12.2005
Language:EN
[2005/48]
Type: A1 Application with search report 
No.:EP1758597
Date:07.03.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 01.12.2005 takes the place of the publication of the European patent application.
[2007/10]
Type: B1 Patent specification 
No.:EP1758597
Date:12.09.2012
Language:EN
[2012/37]
Search report(s)International search report - published on:CA01.12.2005
(Supplementary) European search report - dispatched on:EP28.01.2008
ClassificationIPC:A61K31/702, A61P3/10, A61P5/50, A61K31/27, A61K31/198, A61K31/155, A61K31/4439, A61K31/451, A61K31/5377, A61K31/4965, A61K31/519, A61K31/00
[2007/10]
CPC:
A61K45/06 (EP,US); A61K31/155 (EP,US); A61K31/198 (EP,US);
A61K31/27 (EP,US); A61K31/4439 (EP,US); A61K31/451 (EP,US);
A61K31/4965 (EP,US); A61K31/519 (EP,US); A61K31/5377 (EP,US);
A61K31/702 (EP,US); A61P13/12 (EP); A61P3/04 (EP);
A61P3/06 (EP); A61P3/10 (EP); A61P43/00 (EP);
A61P5/50 (EP); A61P9/00 (EP); A61P9/04 (EP);
A61P9/10 (EP); A61P9/12 (EP) (-)
C-Set:
A61K31/155, A61K2300/00 (US,EP);
A61K31/198, A61K2300/00 (US,EP);
A61K31/27, A61K2300/00 (US,EP);
A61K31/4439, A61K2300/00 (US,EP);
A61K31/451, A61K2300/00 (EP,US);
A61K31/4965, A61K2300/00 (EP,US);
A61K31/519, A61K2300/00 (EP,US);
A61K31/5377, A61K2300/00 (EP,US);
A61K31/702, A61K2300/00 (EP,US)
(-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/10]
TitleGerman:VERWENDUNG VON ARZNEIMITTELKOMBINATIONEN ZUR BEHANDLUNG DER INSULINRESISTENZ[2007/10]
English:USE OF DRUG COMBINATIONS FOR TREATING INSULIN RESISTANCE[2007/10]
French:UTILISATION DE COMBINAISONS MEDICAMENTEUSES POUR TRAITER LA RESISTANCE A L'INSULINE[2007/10]
Entry into regional phase20.12.2006National basic fee paid 
20.12.2006Search fee paid 
20.12.2006Designation fee(s) paid 
20.12.2006Examination fee paid 
Examination procedure20.12.2006Examination requested  [2007/10]
10.03.2009Despatch of a communication from the examining division (Time limit: M06)
21.09.2009Reply to a communication from the examining division
14.06.2011Despatch of a communication from the examining division (Time limit: M04)
13.10.2011Reply to a communication from the examining division
03.02.2012Communication of intention to grant the patent
13.06.2012Fee for grant paid
13.06.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  10.03.2009
Opposition(s)13.06.2013No opposition filed within time limit [2013/34]
Fees paidRenewal fee
31.05.2007Renewal fee patent year 03
31.03.2008Renewal fee patent year 04
25.05.2009Renewal fee patent year 05
31.03.2010Renewal fee patent year 06
26.05.2011Renewal fee patent year 07
30.03.2012Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU20.05.2005
AT12.09.2012
BE12.09.2012
CY12.09.2012
CZ12.09.2012
DK12.09.2012
EE12.09.2012
FI12.09.2012
IT12.09.2012
LT12.09.2012
MC12.09.2012
NL12.09.2012
PL12.09.2012
RO12.09.2012
SE12.09.2012
SI12.09.2012
SK12.09.2012
TR12.09.2012
BG12.12.2012
GR13.12.2012
ES23.12.2012
IS12.01.2013
PT14.01.2013
IE20.05.2013
LU20.05.2013
CH31.05.2013
LI31.05.2013
[2015/34]
Former [2015/32]AT12.09.2012
BE12.09.2012
CY12.09.2012
CZ12.09.2012
DK12.09.2012
EE12.09.2012
FI12.09.2012
IT12.09.2012
LT12.09.2012
MC12.09.2012
NL12.09.2012
PL12.09.2012
RO12.09.2012
SE12.09.2012
SI12.09.2012
SK12.09.2012
TR12.09.2012
BG12.12.2012
GR13.12.2012
ES23.12.2012
IS12.01.2013
PT14.01.2013
IE20.05.2013
CH31.05.2013
LI31.05.2013
Former [2014/20]AT12.09.2012
BE12.09.2012
CY12.09.2012
CZ12.09.2012
DK12.09.2012
EE12.09.2012
FI12.09.2012
IT12.09.2012
LT12.09.2012
MC12.09.2012
NL12.09.2012
PL12.09.2012
RO12.09.2012
SE12.09.2012
SI12.09.2012
SK12.09.2012
BG12.12.2012
GR13.12.2012
ES23.12.2012
IS12.01.2013
PT14.01.2013
IE20.05.2013
CH31.05.2013
LI31.05.2013
Former [2014/08]AT12.09.2012
BE12.09.2012
CY12.09.2012
CZ12.09.2012
DK12.09.2012
EE12.09.2012
FI12.09.2012
IT12.09.2012
LT12.09.2012
MC12.09.2012
NL12.09.2012
PL12.09.2012
RO12.09.2012
SE12.09.2012
SI12.09.2012
SK12.09.2012
BG12.12.2012
GR13.12.2012
ES23.12.2012
IS12.01.2013
PT14.01.2013
CH31.05.2013
LI31.05.2013
Former [2014/03]AT12.09.2012
BE12.09.2012
CY12.09.2012
CZ12.09.2012
DK12.09.2012
EE12.09.2012
FI12.09.2012
IT12.09.2012
LT12.09.2012
MC12.09.2012
NL12.09.2012
PL12.09.2012
RO12.09.2012
SE12.09.2012
SI12.09.2012
SK12.09.2012
BG12.12.2012
GR13.12.2012
ES23.12.2012
IS12.01.2013
PT14.01.2013
Former [2013/37]AT12.09.2012
BE12.09.2012
CY12.09.2012
CZ12.09.2012
DK12.09.2012
EE12.09.2012
FI12.09.2012
IT12.09.2012
LT12.09.2012
NL12.09.2012
PL12.09.2012
RO12.09.2012
SE12.09.2012
SI12.09.2012
SK12.09.2012
BG12.12.2012
GR13.12.2012
ES23.12.2012
IS12.01.2013
PT14.01.2013
Former [2013/34]AT12.09.2012
BE12.09.2012
CY12.09.2012
CZ12.09.2012
DK12.09.2012
EE12.09.2012
FI12.09.2012
LT12.09.2012
NL12.09.2012
PL12.09.2012
RO12.09.2012
SE12.09.2012
SI12.09.2012
SK12.09.2012
BG12.12.2012
GR13.12.2012
ES23.12.2012
IS12.01.2013
PT14.01.2013
Former [2013/31]AT12.09.2012
BE12.09.2012
CY12.09.2012
CZ12.09.2012
EE12.09.2012
FI12.09.2012
LT12.09.2012
NL12.09.2012
PL12.09.2012
RO12.09.2012
SE12.09.2012
SI12.09.2012
SK12.09.2012
GR13.12.2012
ES23.12.2012
IS12.01.2013
PT14.01.2013
Former [2013/28]BE12.09.2012
CY12.09.2012
CZ12.09.2012
EE12.09.2012
FI12.09.2012
LT12.09.2012
NL12.09.2012
PL12.09.2012
RO12.09.2012
SE12.09.2012
SI12.09.2012
SK12.09.2012
GR13.12.2012
ES23.12.2012
IS12.01.2013
PT14.01.2013
Former [2013/23]BE12.09.2012
CY12.09.2012
CZ12.09.2012
EE12.09.2012
FI12.09.2012
LT12.09.2012
NL12.09.2012
PL12.09.2012
RO12.09.2012
SE12.09.2012
SI12.09.2012
SK12.09.2012
GR13.12.2012
ES23.12.2012
IS12.01.2013
Former [2013/22]BE12.09.2012
CY12.09.2012
CZ12.09.2012
EE12.09.2012
FI12.09.2012
LT12.09.2012
NL12.09.2012
SE12.09.2012
SI12.09.2012
GR13.12.2012
ES23.12.2012
IS12.01.2013
Former [2013/20]BE12.09.2012
CY12.09.2012
FI12.09.2012
LT12.09.2012
SE12.09.2012
SI12.09.2012
GR13.12.2012
Former [2013/12]CY12.09.2012
FI12.09.2012
LT12.09.2012
SE12.09.2012
SI12.09.2012
GR13.12.2012
Former [2013/11]CY12.09.2012
FI12.09.2012
LT12.09.2012
SI12.09.2012
GR13.12.2012
Former [2013/10]CY12.09.2012
FI12.09.2012
LT12.09.2012
Former [2013/09]FI12.09.2012
LT12.09.2012
Former [2013/08]LT12.09.2012
Documents cited:Search[X]WO03061648  (LAUTT WAYNE W [CA], et al) [X] 1-6,20,28-35 * page 11, line 1 - page 12, line 40 * * claims 9-12 *;
 [X]WO03061638  (LAUTT WAYNE W [CA], et al) [X] 1-6,19,28-35 * page 9, line 3 - page 11, line 7 * * claims 10-16,22-31 *;
 [X]WO03061639  (LAUTT W WAYNE [CA], et al) [X] 1-21,28-36 * page 6, lines 14-21 * * page 7, lines 4-18 * * page 10, line 24 - page 11, line 47 * * example 2 * * claim - *;
 [PA]  - LAUTT W WAYNE, "A new paradigm for diabetes and obesity: the hepatic insulin sensitizing substance (HISS) hypothesis", JOURNAL OF PHARMACOLOGICAL SCIENCES, (200405), vol. 95, no. 1, ISSN 1347-8613, pages 9 - 17, XP002463281 [PA] 1-36 * the whole document *

DOI:   http://dx.doi.org/10.1254/jphs.95.9
 [XA]  - CHARPENTIER GUILLAUME, "Oral combination therapy for type 2 diabetes.", DIABETES/METABOLISM RESEARCH AND REVIEWS 2002 SEP-OCT, (200209), vol. 18 Suppl 3, ISSN 1520-7552, pages S70 - S76, XP002463282 [X] 1 * page S72, column 2, paragraph 4 - page S75, column 1, paragraph 1 * [A] 1-36

DOI:   http://dx.doi.org/10.1002/dmrr.278
International search[Y]US5561165  (LAUTT W WAYNE [CA], et al);
 [X]CA2415392  (KERI PHARMA KFT [HU]);
 [X]CA2465632  (PFIZER PROD INC [US]);
 [A]  - LAUTT W.W., "The HISS story overview: a novel hepatic neurohumoral regulation of peripheral insulin sensitivity in health and diabetes", CAN. J. PHYSIOL. PHARMACOL., (1999), vol. 77, pages 553 - 562, XP009011015

DOI:   http://dx.doi.org/10.1139/cjpp-77-8-553
by applicantUS5561165
 WO0019992
 WO03061648
 WO03061638
 WO03061639
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.